The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • Department of Defense funds $8 million grant for Long COVID trials

    Department of Defense funds $8 million grant for Long COVID trials

    Betsy Ladyzhets

    A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant. Read more…

Recent articles

  • National COVID-19 trends, September 1
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, September 1

  • Research updates, September 1
    Science
    Miles W. Griffis

    Research updates, September 1

  • “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID
    Commentary
    Kelly Sealey

    “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Department of Defense funds $8 million grant for Long COVID trialsDepartment of Defense funds $8 million grant for Long COVID trialsBetsy Ladyzhets
“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVIDKelly Sealey
National COVID-19 trends, August 25National COVID-19 trends, August 25Betsy Ladyzhets
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis
Research updates, August 25Research updates, August 25Miles W. Griffis

Policy & Advocacy

Science

  • person getting vaccinated
    June 18, 2024

    Research updates, June 18

  • depth photography of blue and white medication pill
    June 11, 2024

    Research updates, June 11

  • gray plane wing
    June 4, 2024

    Research updates, June 4

  • May 31, 2024

    ‘They bungled it:’ NIH documents reveal how $1.6 billion Long Covid initiative has failed so far to meet its goals

  • pexels-photo-3993241.jpeg
    May 28, 2024

    Research updates, May 28

  • woman writing on a whiteboard
    May 21, 2024

    Research updates, May 21

Previous Page
1 … 29 30 31 32 33 … 38
Next Page

Covid-19

  • November 14, 2023

    National Covid-19 trends, November 14

Previous Page
1 … 29 30 31

Health

Commentary

  • November 14, 2023

    Welcome to The Sick Times, a letter from our co-founder, Betsy Ladyzhets

  • woman in beige coat standing near white wooden book shelf
    November 14, 2023

    We want to hear from you! Take our reader survey

Previous Page
1 … 25 26 27

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...